// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Evolution from mild to severe asthma; the severe asthma clinic perspective

Darsana Viswam - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study

Jrgen Vestbo - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Mortality and disease burden in the North-West England severe asthma population

Daniel Crowle - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Predicting early vs late vs no re-exacerbation in COPD patients:Analysis of ECLIPSE cohort

Marion Fahey - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Characterisation of the bronchial epithelium in COPD frequent exacerbators

Andrew Higham - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Exacerbation and pneumonia risk models: methodology and results from the IMPACT trial

Benjamin Hartley - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Regional analysis of COPD exacerbation rates in the DYNAGITO trial

Klaus F. Rabe - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Tiotropium/olodaterol

Antibiotic choice and repeat prescriptions in infective COPD exacerbations

Marie Stolbrink - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Assessment of Inter- and Intra-Rater Reliability of Objective Cough Frequency in Patients with Chronic Cough

Daniel Mines - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prevotella genera abundance in bronchial brush samples differentiates COPD from health and is associated with gene expression

Mohammadali Yavari Ramsheh - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Frailty in COPD inpatients, does it affect length of stay and mortality?

Bethia Bradley - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Identifying tools to investigate outcomes following an exacerbation of COPD

Pamela Burrage - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The risk of hyperkalemia in COPD and asthma patients

Jukka Menp - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Hyperkalemia

N/A

Do DECAF scores for acute exacerbation of COPD correlate with hospital anxiety and depression scale?

Nirav Shah - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Depression

N/A

Group-delivered speech and language therapy for chronic refractory cough: what do patients want?

Julia Selby - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Automated cell differential count in sputum is feasible and comparable to manual cell count in identifying eosinophilia

Laurits Frssing - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Factors associated with prolonged duration of AECOPD:Analysis of the ECLIPSE cohort

Marion Fahey - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Predicting Recurrent Oral Corticosteroid Use in the WATCH cohort

Anna Freeman - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Does Aspergillus fungal sensitisation define asthma severity in difficult asthma? Findings from WATCH

Heena Mistry - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Association between cough frequency, health status and Th2 inflammation in severe asthma

Joshua Holmes - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Copyright © 2026. QuantiNova All rights reserved